Webdoses of warfarin. Prior to initiation of warfarin: Ensure no contraindications to anticoagulation Ensure patient is not on other oral anticoagulants, i.e. dabigatran, rivaroxaban, apixaban,edoxaban (Note: if switching from one of these anticoagulants to warfarin, a period of overlap will be required – see Guidance on WebNHSGGC guidance states that patients with non-valvular atrial fibrillation (AF), who are believed to be adhering to warfarin therapy but have a poorly controlled INR, should be considered for a Novel Oral Anticoagulant (NOAC). A poorly controlled INR in this context is defined as therapeutic INR < 60% of the time.
Scenario: Apixaban Management Anticoagulation - oral CKS
WebInitiation and monitoring of warfarin therapy. Urgent anticoagulation required – use the Age-adjusted warfarin induction regimen and cover with enoxaparin (see NHSGGC StaffNet / Clinical Info / Clinical Guidelines Directory and search for 'warfarin induction protocols').. Anticoagulation not urgent – consider a slower regime such as low-slow-start warfarin. WebWarfarin. Anticoagulation and Antiplatelet Management, Pleural Disease Investigation and Treatment (637) Anticoagulation and Head Injuries in the Emergency Department (026) Management of Warfarin, DOAC and Antiplatelet Therapy in Patients Admitted with Hip … stiege camping
Thromboprophylaxis for Medical and Surgical Patients - GGC …
WebThe recommended dose is 5 mg twice daily. The dose should be reduced to 2.5 mg twice daily in people with: At least two of the following characteristics: age 80 years or over, body weight 60 kg or less, serum creatinine 133 micromol/L or over. Creatinine clearance (CrCl) 15–29 mL/minute. Treatment is usually long term. WebSee the Antiplatelet guideline and antiplatelet guidance following stroke. Consider offering additional VTE prophylaxis to patients taking antiplatelet agents assessed to be at increased risk of VTE (see Table 1 above), taking into account the increased risk of bleeding. Pre-existing established warfarin or direct oral anticoagulant (DOAC) therapy WebOct 7, 2016 · antiplatelet agents anticoagulants perioperative Warfarin peri-operative thrombosis surgery bleeding thrombosis antiplatelet. Declaration of Interests. The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and ... stieger treuhand team